Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 385

1.

Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls.

Zoppini G, Bergamini C, Trombetta M, Sabbagh L, Dauriz M, Mantovani A, Targher G, Fossà I, Rinaldi E, Bonora E.

J Endocrinol Invest. 2019 Mar 16. doi: 10.1007/s40618-019-01032-7. [Epub ahead of print]

PMID:
30877659
2.

Letter: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density-authors' reply.

Targher G, Mantovani A, Dauriz M, Bonnet F, Byrne CD.

Aliment Pharmacol Ther. 2019 Apr;49(7):961-962. doi: 10.1111/apt.15181. No abstract available.

3.

Association between increased carotid intima-media thickness and higher serum levels of C-terminal telopeptide of typecollagen in postmenopausal women with type 2 diabetes.

Mantovani A, Altomari A, Fassio A, Gatti D, Bonnet F, Targher G.

Diabetes Metab. 2019 Mar 4. pii: S1262-3636(19)30032-1. doi: 10.1016/j.diabet.2019.02.005. [Epub ahead of print] No abstract available.

PMID:
30844448
4.

Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease.

Mantovani A, Zusi C, Sani E, Colecchia A, Lippi G, Zaza GL, Valenti L, Byrne CD, Maffeis C, Bonora E, Targher G.

Diabetes Metab. 2019 Feb 11. pii: S1262-3636(19)30026-6. doi: 10.1016/j.diabet.2019.01.011. [Epub ahead of print]

PMID:
30763699
5.

Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?

Lonardo A, Ballestri S, Mantovani A, Nascimbeni F, Lugari S, Targher G.

Dig Liver Dis. 2019 Jan 2. pii: S1590-8658(18)31442-7. doi: 10.1016/j.dld.2018.12.014. [Epub ahead of print] Review.

PMID:
30733187
6.

Association Between Nonalcoholic Fatty Liver Disease and Reduced Bone Mineral Density in Children: A Meta-Analysis.

Mantovani A, Gatti D, Zoppini G, Lippi G, Bonora E, Byrne CD, Nobili V, Targher G.

Hepatology. 2019 Jan 31. doi: 10.1002/hep.30538. [Epub ahead of print]

PMID:
30706504
7.

Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.

Mantovani A, Dauriz M, Sandri D, Bonapace S, Zoppini G, Tilg H, Byrne CD, Targher G.

Liver Int. 2019 Jan 18. doi: 10.1111/liv.14044. [Epub ahead of print]

PMID:
30657626
8.

Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density.

Mantovani A, Dauriz M, Gatti D, Viapiana O, Zoppini G, Lippi G, Byrne CD, Bonnet F, Bonora E, Targher G.

Aliment Pharmacol Ther. 2019 Feb;49(4):375-388. doi: 10.1111/apt.15087. Epub 2019 Jan 1. Review.

PMID:
30600540
9.

The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.

Zoppini G, Bergamini C, Mantovani A, Dauriz M, Targher G, Rossi A, Bonora E.

PLoS One. 2018 Dec 27;13(12):e0209794. doi: 10.1371/journal.pone.0209794. eCollection 2018.

10.

Association of Plasma Ceramides With Myocardial Perfusion in Patients With Coronary Artery Disease Undergoing Stress Myocardial Perfusion Scintigraphy.

Mantovani A, Bonapace S, Lunardi G, Salgarello M, Dugo C, Gori S, Barbieri E, Verlato G, Laaksonen R, Byrne CD, Targher G.

Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):2854-2861. doi: 10.1161/ATVBAHA.118.311927.

PMID:
30571175
11.

Does high LDL-cholesterol cause cardiovascular disease?

Targher G, Bonapace S, Byrne CD.

Expert Rev Clin Pharmacol. 2019 Feb;12(2):91. doi: 10.1080/17512433.2019.1561100. Epub 2018 Dec 26. No abstract available.

PMID:
30570363
12.

Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes.

Mantovani A, Sani E, Fassio A, Colecchia A, Viapiana O, Gatti D, Idolazzi L, Rossini M, Salvagno G, Lippi G, Zoppini G, Byrne CD, Bonora E, Targher G.

Diabetes Metab. 2018 Oct 10. pii: S1262-3636(18)30195-2. doi: 10.1016/j.diabet.2018.10.001. [Epub ahead of print]

PMID:
30315891
13.

Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes.

Mantovani A, Rigolon R, Turino T, Pichiri I, Falceri A, Rossi A, Temporelli PL, Bonapace S, Lippi G, Zoppini G, Bonora E, Byrne CD, Targher G.

Diabetes Metab. 2018 Dec;44(6):473-481. doi: 10.1016/j.diabet.2018.08.007. Epub 2018 Sep 5.

PMID:
30195089
14.

Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Mantovani A, Nascimbeni F, Lonardo A, Zoppini G, Bonora E, Mantzoros CS, Targher G.

Thyroid. 2018 Oct;28(10):1270-1284. doi: 10.1089/thy.2018.0257. Epub 2018 Aug 30.

PMID:
30084737
15.

Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study.

Mazzola R, Fersino S, Ferrera G, Targher G, Figlia V, Triggiani L, Pasinetti N, Lo Casto A, Ruggieri R, Magrini SM, Alongi F.

Med Oncol. 2018 Aug 4;35(9):121. doi: 10.1007/s12032-018-1190-8.

PMID:
30076479
16.

Ad Libitum Mediterranean or Low-Fat Diets as Treatments for Nonalcoholic Fatty Liver Disease?

Targher G, Byrne CD.

Hepatology. 2018 Nov;68(5):1668-1671. doi: 10.1002/hep.30142. Epub 2018 Oct 11. No abstract available.

PMID:
30070378
17.

Tests for diagnosing and monitoring non-alcoholic fatty liver disease in adults.

Byrne CD, Patel J, Scorletti E, Targher G.

BMJ. 2018 Jul 12;362:k2734. doi: 10.1136/bmj.k2734. No abstract available.

PMID:
30002017
18.

Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes.

Zoppini G, Bergamini C, Bonapace S, Trombetta M, Mantovani A, Toffalini A, Lanzoni L, Bertolini L, Zenari L, Bonora E, Targher G, Rossi A.

BMJ Open Diabetes Res Care. 2018 Jun 14;6(1):e000529. doi: 10.1136/bmjdrc-2018-000529. eCollection 2018.

19.

Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.

Mantovani A, Dauriz M, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G.

Metabolism. 2018 Oct;87:1-12. doi: 10.1016/j.metabol.2018.06.004. Epub 2018 Jun 20.

PMID:
29935236
20.

Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy.

Mantovani A, Bonapace S, Lunardi G, Salgarello M, Dugo C, Canali G, Byrne CD, Gori S, Barbieri E, Targher G.

Metabolism. 2018 Aug;85:305-312. doi: 10.1016/j.metabol.2018.05.006. Epub 2018 May 16.

PMID:
29777715
21.

Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure.

Valbusa F, Agnoletti D, Scala L, Grillo C, Arduini P, Bonapace S, Calabria S, Scaturro G, Mantovani A, Zoppini G, Turcato E, Maggioni AP, Arcaro G, Targher G.

Int J Cardiol. 2018 Aug 15;265:162-168. doi: 10.1016/j.ijcard.2018.04.129. Epub 2018 May 2.

PMID:
29739707
22.

Liver fat content, non-alcoholic fatty liver disease, and risk of ischaemic heart disease.

Byrne CD, Targher G.

Eur Heart J. 2018 Sep 21;39(36):3398. doi: 10.1093/eurheartj/ehy237. No abstract available.

PMID:
29726934
23.

Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease.

Anstee QM, Mantovani A, Tilg H, Targher G.

Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):425-439. doi: 10.1038/s41575-018-0010-0. Review.

PMID:
29713021
24.

Mortality from infectious diseases in diabetes.

Zoppini G, Fedeli U, Schievano E, Dauriz M, Targher G, Bonora E, Corti MC.

Nutr Metab Cardiovasc Dis. 2018 May;28(5):444-450. doi: 10.1016/j.numecd.2017.12.007. Epub 2018 Jan 31.

PMID:
29519560
25.

Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.

Mantovani A, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI-HF Investigators.

Metabolism. 2018 Jun;83:205-215. doi: 10.1016/j.metabol.2018.02.007. Epub 2018 Mar 29.

PMID:
29477817
26.

From a fatty liver to a sugary blood.

Lonardo A, Targher G.

Dig Liver Dis. 2018 Apr;50(4):378-380. doi: 10.1016/j.dld.2018.01.126. Epub 2018 Feb 2. No abstract available.

PMID:
29422241
27.

Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.

Cacciatori V, Zoppini G, Bellavere F, Rigolon R, Thomaseth K, Pichiri I, Trombetta M, Dauriz M, De Santi F, Targher G, Santi L, Bonora E.

J Endocr Soc. 2017 Nov 6;2(1):53-62. doi: 10.1210/js.2017-00300. eCollection 2018 Jan 1.

28.

Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.

Mantovani A, Byrne CD, Bonora E, Targher G.

Diabetes Care. 2018 Feb;41(2):372-382. doi: 10.2337/dc17-1902. Review.

PMID:
29358469
29.

Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Targher G, Lonardo A, Byrne CD.

Nat Rev Endocrinol. 2018 Feb;14(2):99-114. doi: 10.1038/nrendo.2017.173. Epub 2017 Dec 29. Review.

PMID:
29286050
30.

Psoriasis and the metabolic syndrome.

Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G.

Clin Dermatol. 2018 Jan - Feb;36(1):21-28. doi: 10.1016/j.clindermatol.2017.09.005. Epub 2017 Sep 8. Review.

PMID:
29241748
31.

Clinical relevance of liver histopathology and different histological classifications of NASH in adults.

Nascimbeni F, Ballestri S, Machado MV, Mantovani A, Cortez-Pinto H, Targher G, Lonardo A.

Expert Rev Gastroenterol Hepatol. 2018 Apr;12(4):351-367. doi: 10.1080/17474124.2018.1415756. Epub 2017 Dec 26. Review.

PMID:
29224471
32.

Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.

Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G.

Metabolism. 2018 Feb;79:64-76. doi: 10.1016/j.metabol.2017.11.003. Epub 2017 Nov 11. Review.

PMID:
29137912
33.

Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?

Lonardo A, Nascimbeni F, Mantovani A, Targher G.

J Hepatol. 2018 Feb;68(2):335-352. doi: 10.1016/j.jhep.2017.09.021. Epub 2017 Nov 6. Review.

PMID:
29122390
34.

Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis.

Dauriz M, Mantovani A, Bonapace S, Verlato G, Zoppini G, Bonora E, Targher G.

Diabetes Care. 2017 Nov;40(11):1597-1605. doi: 10.2337/dc17-0697. Review.

PMID:
29061587
35.

Relation of elevated serum uric acid levels to first-degree heart block and other cardiac conduction defects in hospitalized patients with type 2 diabetes.

Mantovani A, Rigolon R, Pichiri I, Morani G, Bonapace S, Dugo C, Zoppini G, Bonora E, Targher G.

J Diabetes Complications. 2017 Dec;31(12):1691-1697. doi: 10.1016/j.jdiacomp.2017.09.011. Epub 2017 Sep 20.

PMID:
29033310
36.

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.

Mantovani A, Rigolon R, Pichiri I, Bonapace S, Morani G, Zoppini G, Bonora E, Targher G.

PLoS One. 2017 Oct 5;12(10):e0185459. doi: 10.1371/journal.pone.0185459. eCollection 2017.

37.

NAFLD: Is There Anything New under the Sun?

Lonardo A, Targher G.

Int J Mol Sci. 2017 Sep 12;18(9). pii: E1955. doi: 10.3390/ijms18091955.

38.

A fatty liver leads to decreased kidney function?

Targher G, Francque SM.

J Hepatol. 2017 Dec;67(6):1137-1139. doi: 10.1016/j.jhep.2017.08.018. Epub 2017 Sep 18. No abstract available.

PMID:
28870673
39.

Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.

Mantovani A, Targher G.

Ann Transl Med. 2017 Jul;5(13):270. doi: 10.21037/atm.2017.04.41. Review.

40.

Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose.

Carnevale R, Pastori D, Nocella C, Cammisotto V, Baratta F, Del Ben M, Angelico F, Sciarretta S, Bartimoccia S, Novo M, Targher G, Violi F.

Nutr Metab Cardiovasc Dis. 2017 Oct;27(10):890-895. doi: 10.1016/j.numecd.2017.06.007. Epub 2017 Jun 19.

PMID:
28743559
41.

Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.

Mantovani A, Rigolon R, Civettini A, Bolzan B, Morani G, Bonapace S, Dugo C, Zoppini G, Bonora E, Targher G.

J Endocrinol Invest. 2018 Feb;41(2):223-231. doi: 10.1007/s40618-017-0729-4. Epub 2017 Jul 15.

PMID:
28711969
42.

Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial.

Dauriz M, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI‐HF Investigators.

J Am Heart Assoc. 2017 Jul 5;6(7). pii: e005156. doi: 10.1161/JAHA.116.005156.

43.

Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.

Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Targher G, Lonardo A.

Metabolism. 2017 Jul;72:57-65. doi: 10.1016/j.metabol.2017.04.003. Epub 2017 Apr 13.

PMID:
28641784
44.

Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design.

Violi F, Targher G, Vestri A, Carnevale R, Averna M, Farcomeni A, Lenzi A, Angelico F, Cipollone F, Pastori D.

Am Heart J. 2017 Jul;189:120-127. doi: 10.1016/j.ahj.2017.04.005. Epub 2017 Apr 18.

PMID:
28625368
45.

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Adams LA, Anstee QM, Tilg H, Targher G.

Gut. 2017 Jun;66(6):1138-1153. doi: 10.1136/gutjnl-2017-313884. Epub 2017 Mar 17. Review.

PMID:
28314735
46.

Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.

Valbusa F, Bonapace S, Agnoletti D, Scala L, Grillo C, Arduini P, Turcato E, Mantovani A, Zoppini G, Arcaro G, Byrne C, Targher G.

PLoS One. 2017 Mar 13;12(3):e0173398. doi: 10.1371/journal.pone.0173398. eCollection 2017.

47.

Psychological distress, self-efficacy and glycemic control in type 2 diabetes.

Indelicato L, Dauriz M, Santi L, Bonora F, Negri C, Cacciatori V, Targher G, Trento M, Bonora E.

Nutr Metab Cardiovasc Dis. 2017 Apr;27(4):300-306. doi: 10.1016/j.numecd.2017.01.006. Epub 2017 Jan 31.

PMID:
28274728
48.

Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function.

Zoppini G, Bergamini C, Bonapace S, Rossi A, Trombetta M, Mantovani A, Toffalini A, Lanzoni L, Bertolini L, Zenari L, Bonora E, Targher G.

J Diabetes Complications. 2017 Jun;31(6):1035-1040. doi: 10.1016/j.jdiacomp.2017.01.021. Epub 2017 Feb 13.

PMID:
28258906
49.

Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry.

Dauriz M, Targher G, Laroche C, Temporelli PL, Ferrari R, Anker S, Coats A, Filippatos G, Crespo-Leiro M, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L; ESC-HFA Heart Failure Long-Term Registry.

Diabetes Care. 2017 May;40(5):671-678. doi: 10.2337/dc16-2016. Epub 2017 Mar 2.

PMID:
28255009
50.

Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes.

Mantovani A, Rigolon R, Mingolla L, Pichiri I, Cavalieri V, Salvotelli L, Stoico V, Zoppini G, Bonora E, Targher G.

J Diabetes Complications. 2017 Jun;31(6):1021-1026. doi: 10.1016/j.jdiacomp.2017.01.024. Epub 2017 Feb 12.

PMID:
28254449

Supplemental Content

Loading ...
Support Center